Showing results (1611-1620 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|May 14, 2025
Advancing breast cancer rehabilitation: a novel tool for assessing physical morbidity riskIfat Klein, Merav A Ben David, Danit R Shahar, et al.
The Oncologist|May 16, 2025
Clinicopathological characteristics of progressive gastrointestinal stromal tumors and heterogeneity analyses of secondary mutationsJiaxin Li, Lin Sun, Shasha Liu, et al.
The Oncologist|June 19, 2025
REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimensJeffrey Zhong, Albert Jang, Bashar Abuqayas, et al.
The Oncologist|June 12, 2025
The Association of Health Care Contact Days with Economic Measures in the CCTG LY.12 TrialArjun Gupta, Tyler Thomas, Annette E Hay, et al.
The Oncologist|June 10, 2025
Baseline total lesion glycolysis identifies high-risk patients with immunosuppressive signatures in early-stage natural killer/T-cell lymphomaXiao Gao, Jie Xiong, Xin-Yun Huang, et al.
The Oncologist|May 11, 2025
Efficacy and safety of dacomitinib in treatment-naïve patients with advanced NSCLC and brain metastasis: a multicenter cohort studyPuyuan Xing, Xingxiang Pu, Yu Zhou, et al.
The Oncologist|May 11, 2025
Correlation between tumor growth rate and survival in patients with metastatic breast cancer treated with trastuzumab deruxtecanPhilip He, Dhiraj Gambhire, Haiming Zhou, et al.
The Oncologist|May 8, 2025
Real-world treatment and outcomes for EGFR WT advanced/metastatic non-squamous non-small cell lung cancer: pooled analysis from project LUMINATE-101Nicolas Girard, Qingqing Xu, D Ross Camidge, et al.
The Oncologist|August 21, 2025
Efficacy Outcomes Between Tarlatamab and Real-World Physicians' Choice of Therapies for Previously Treated Extensive Stage Small Cell Lung CancerJessie Wang, Gautam Sajeev, Xinglei Chai, et al.
The Oncologist|February 17, 2026
Toripalimab in Patients with Previously Treated Advanced Upper Tract Urothelial Carcinoma: A Subgroup Analysis of the Phase II POLARIS-03 TrialJinchang Wei, Ruiyun Zhang, Juan Li, et al.
Pageof 571